novo oral glp 1 Novo's Rybelsus gains FDA expansion to reduce risk of MACE FDA approves Novo Nordisk's oral

Figure 1: Gut microbiome modulation of GLP-1driven neuroendocrine signaling

doi: 10.1056/NEJMoa2202106

doi: 10.1007/s00281-013-0362-z 28 GuarinoCHamonYCroixCLamortASDallet-ChoisySMarchand-AdamSet al

[1] Managing Increased Urination While Taking GLP-1 Medications If you are experiencing increased urination whilst taking GLP-1 medication, several practical strategies can help manage this symptom whilst ensuring your treatment remains effective: Monitor your fluid intake : Maintain adequate hydration (NHS recommends 6-8 cups or glasses of fluid per day for most adults) but avoid excessive fluid consumption unless medically advised

The same digestive-slowing effect that may help patients lose weight is also central to current allegations involving gastroparesis, stomach paralysis, and other severe gastrointestinal complications